SlideShare a Scribd company logo
1 of 17
Download to read offline
Woodley BioReg Limited
Company and Services Overview
WBR JAN 2016
Woodley BioReg Limited
WoodleyBioReg
 Company Background
 Services
 Regulatory Affairs Support
 Quality Support
 Import Services
 Training Services
 Areas of Expertise
 Examples of Products Registered and Maintained by WBR
 Examples of Current Global Projects
Company Background
WoodleyBioReg
 Established in 2001
 Headquarters in the UK
 Permanent Employees reinforced by a network of Specialist Associates
 Operate Globally
 Europe, USA, India, China, South Korea Australia………..
Services
WoodleyBioReg
 Provide Regulatory, Quality, Import Services and Training
 Work with you, the manufacturers and suppliers of:
 Biopharmaceuticals / biologics / biosimilars
 Pharmaceuticals
 Generics
 Healthcare / Over-the-Counter Medicines
 Active Pharmaceutical Ingredients (APIs)
 Medical Devices
Training
Import
Services
QualityRegulatory
WoodleyBioReg
Overview of EU cGMP Registration Process
Registration
cGMP
Gap Analysis
Audit
Technical Plant/
Documents
Review/Finalise
Submission
Draft Submission
Submit (Nees / eCTD)
to BoH / EMA
EU Audit
Approval
Market Product
Remediation Report
Remediation Deficiencies
Audit and Approval
Maintain cGMP
Compliance
Existing Reg.
Affairs Docs
Regulatory Affairs Support – Key Services
WoodleyBioReg
 Flexible Resourcing
 Day-to day support for function activities
 Qualified resources with 2 to 25+ years of experience
 Ex-Industry, ex-Agency (MHRA, BfArM, EMA, Health Canada, FDA, etc.)
 Registration Drift
 MA compliance and conformance assessment
 Agency “approved” dossier review and remediation procedure - published
 Applied to over 8,000 MAs
 Permanent fix that link the MAs into change control procedures
 Licence Makeover
 Allows easy maintenance of well-established products
 Simplifies variations
 Can be combined with other initiatives, e.g. Registration Drift
 Import Service
 Allows non-EU clients to make a soft landing for EU commercialisation
Regulatory Affairs Support – Flexible Resourcing
WoodleyBioReg
 Submission Strategy Development
 DCP / MRP / CP / duplicate licences / COO etc.
 Write and submit Marketing Authorisations / Product Licences
 m1 through to m5
 Publishing - NeeS (EU) or eCTD (US)
 Respond to Requests for Information (RFIs)
 Attend Agency Meetings with Boards of Health (and Scientific Advice)
 Licence Maintenance / Life-Cycle Management
 Change of ownership
 Variations and Renewals
 Compliance and Conformance specialists for top tier pharmaceutical companies
 Provide EU Regulatory Affairs office for overseas (non-EU) clients
Regulatory Affairs Support – Registration Drift
WoodleyBioReg
Gap
Analysis
Load RemediationCollation
Risk-based
Schedule
Prioritise products, collect MAs,
collate details in a single central
location, and prepare to perform
a GAP ANALYSIS
Prepare and file variations to
align the MAs and maintain under
Change Control
Compare MA sections to Plant /
Manufacturing documents, prioritise
the differences.
Regulatory Affairs Support – Licence Makeover
WoodleyBioReg
3.2.P.1
DS
DP
PDF
NtA
Scans
PDF
NtA
Scans
PDF
NtA
Scans
Paper
PDF
NtA
Scans
Variations
3.2.S.1
eRepository
Current MAs, Variations, etc
Extracted and organised
into CTD (DS / DP) folders
Compliance and Conformance
reviewed CTD / SRC dossier
sections
MA Visibility / Maintenance
(under CC)
Extraction
Reformat
& Review
Extraction
1. Take source documents, Scan/OCR
2. Split into DS / DP sections
3. No rewriting undertaken
Reformat & Review
1. Convert into CTD format (templated)
2. Re-write parts as necessary
3. Review content against CTD requirements
4. Identify Gaps / Remediate through variation
Load
- WBR / Client
for Scan / OCR (where
available)
- WBR for load
- Client for ongoing
maintenance
- WBR for review,
reformatting and
Gap Analysis
Import Services
WoodleyBioReg
 Provide EU address
 Laboratory Testing Services:
 Full release
 Batch release
 Identity
 Product quality specification (PQS)
 Stability - storage (temperature and humidity controls) and indicating
 QP sign-off for batch release
 PV contact for Adverse Event reporting (see later)
 Secure, controlled storage of GMP pharmaceutical products
 Shipping and distribution within the EU
 All of the above services are EU legal requirements governed by
 Manufacturer’s Importer’s Authorisation (MIA)
 Wholesale Dealers Licence (WDL)
Quality Support
WoodleyBioReg
 cGMP standards and certification (EU and US)
 Contract QP services (biologics and pharmaceuticals including steriles)
 Full validation and documentation assessment and remediation / re-writes
 Issue WBR EU registered QP certificate
 Quality Management / Quality Assurance System
 Development, refinement/ amendment and deployment of QMS
 Pharmacovigilence
 Including contract QPPV services
 Auditing
 Self-Audits
 Due diligence
 Third party manufacturers
 Remediation plans and assistance
 Training
 GMP and Regulatory Affairs
Pharmacovigilence Support
WoodleyBioReg
 EU QPPV Provision
 Pharmacovigilance System Master File (PSMF)
 generation and maintenance
 Receipt and processing of Serious Adverse Events (SAE) onto ARISg
 Medical Review of ADR reports and submission of expedited reports
 Literature searches (required for PV reporting)
 Periodic Safety Updates (PSURs)
 preparation and distribution of Risk Management Plans (RMPs)
 Signal detection
 EVMPD (PV database) maintenance
 Audits, training and any other incidentals
Training Services
WoodleyBioReg
 cGMP and Quality Systems Requirements
 Regulatory Affairs Submissions
 New Variation Guidelines
 Introduction to European Regulatory Affairs
 How to Register Biosimilars to “Global Standards”
 Pre-approval Inspection Requirements for the US FDA
 How to Audit to cGMP - what to look for in self-audits
 Identification and Validation of Critical Manufacturing Process Steps
Areas of Expertise
WoodleyBioReg
 Biologics / Vaccines
 Biosimilars
 Pharmaceuticals / Generics
 Healthcare / OTC
 Devices (including Drug Device combinations)
 Steriles including pre-filled syringes
 Advanced Therapeutic Medicinal Products (ATMPs)
 Orphan Products
 Metered Dose Inhalers
 Solid dose, gels, and capsules
 Topicals (creams and ointments)
Products WBR have Registered and Maintained
WoodleyBioReg
Examples of products WBR registered and maintained in the EU and US:
 Alpha-reductus Inhibitors
 Analgesic
 Anti-anxiety
 Antibiotic
 Anticholinesterase
 Anticonvulsants
 Antidepressants
 Anti-epileptic
 Antihypertensive
 Antihistamines
 Anti-platlets
 Antipsychotic
 Bi-phosphonates
 Cholinesterase Inhibitors
 Diuretics
 Immunosuppressants
 Laxatives
 Leukotriene Receptor Antagonists (Asthma)
 Meglitinides (Diabetes)
 Oncology
 Proton Pump Inhibitors
 Sedatives
 Statins
 Steroids
 Vaccines
 Anthrax
 Diphtheria
 Hepatitis B
 Influenza
 Meninge
 Pertussis
 Tetanus
 Typhoid
 Yellow Fever
 Vitamin D products
Current Global Projects
WoodleyBioReg
 EU and US Registrations
 Statins / Anti-depressants / Anti-hypertensives / Analgesics / Combination products /
Vaccines etc.
 For Chinese and Indian generics manufacturers
 EU Regulatory and Quality department
 Long-term provision of EU “virtual” regulatory department for an Indian generics
manufacturer
 Submission of all filings to EU Boards of Health
 Quality Management System (QMS) implementation
 Scoping, writing, implementation and ongoing management of a QMS for the UK division
of a Chinese international generics manufacturer
 Global Conformance Review
 Review of >2,000 over-the-counter healthcare products for a multi-national
pharmaceutical company
 Quality Audit of a Manufacturer
 Due diligence audit of a Korean biologics manufacturing company prior to US acquisition
Regulatory and Quality Experts
www.woodleybioreg.com
E: enquiry@woodleybioreg.com
T: +44 (0)1484 434343
Midland Mill, 9-11 Hillhouse Lane, Huddersfield, West Yorkshire, HD1 6EF, UK

More Related Content

What's hot

COMBINATION PRODUCTS – Perspectives on FDA Regulation
COMBINATION PRODUCTS – Perspectives on FDA RegulationCOMBINATION PRODUCTS – Perspectives on FDA Regulation
COMBINATION PRODUCTS – Perspectives on FDA RegulationMichael Swit
 
Marketing Authorization In The Eu
Marketing Authorization In The EuMarketing Authorization In The Eu
Marketing Authorization In The Euclarityeye
 
Presentation: Implementing TGO 101
Presentation: Implementing TGO 101Presentation: Implementing TGO 101
Presentation: Implementing TGO 101TGA Australia
 
"Scientific Exchange -- New Interpretations??"
"Scientific Exchange -- New Interpretations??""Scientific Exchange -- New Interpretations??"
"Scientific Exchange -- New Interpretations??"Michael Swit
 
Federal Regulatory Issues Us Food And Drug Administration Medical Device Amen...
Federal Regulatory Issues Us Food And Drug Administration Medical Device Amen...Federal Regulatory Issues Us Food And Drug Administration Medical Device Amen...
Federal Regulatory Issues Us Food And Drug Administration Medical Device Amen...Jacobe2008
 
Pharmaceutical Industry Terminology
Pharmaceutical Industry TerminologyPharmaceutical Industry Terminology
Pharmaceutical Industry TerminologyThomson Reuters
 
Overview of FDA Drug Manufacturing Requirements
Overview of FDA Drug Manufacturing RequirementsOverview of FDA Drug Manufacturing Requirements
Overview of FDA Drug Manufacturing RequirementsMichael Swit
 
Exam no. 76 ashma
Exam no. 76 ashmaExam no. 76 ashma
Exam no. 76 ashmanirmikaben
 
Eu and usa key differences 1
Eu and usa key differences 1Eu and usa key differences 1
Eu and usa key differences 1Ann McGee
 
Basic concepts about regulatory affairs
Basic concepts about regulatory affairsBasic concepts about regulatory affairs
Basic concepts about regulatory affairsRajkumar Koley
 
Recall of ph product
Recall of ph productRecall of ph product
Recall of ph productAhmed Suhail
 
Drug Regulatory Affairs
Drug Regulatory AffairsDrug Regulatory Affairs
Drug Regulatory AffairsNamdeo Shinde
 
Clinical research : Drug regulatory affairs and Pharmacovigilance.
Clinical research : Drug regulatory affairs and Pharmacovigilance.Clinical research : Drug regulatory affairs and Pharmacovigilance.
Clinical research : Drug regulatory affairs and Pharmacovigilance.ProfDnyaneshwariJosh
 
Introduction to Regulatory Affairs - Pauwels Consulting Academy
Introduction to Regulatory Affairs  - Pauwels Consulting AcademyIntroduction to Regulatory Affairs  - Pauwels Consulting Academy
Introduction to Regulatory Affairs - Pauwels Consulting AcademyPauwels Consulting
 
Presentation Therapeutic Goods (Standard for Tablets, Capsules and Pills) (TG...
Presentation Therapeutic Goods (Standard for Tablets, Capsules and Pills) (TG...Presentation Therapeutic Goods (Standard for Tablets, Capsules and Pills) (TG...
Presentation Therapeutic Goods (Standard for Tablets, Capsules and Pills) (TG...TGA Australia
 
Raaj Global Pharma Regulatory Affairs Consultants Thane-mumbai profile-updat...
Raaj Global Pharma Regulatory Affairs  Consultants Thane-mumbai profile-updat...Raaj Global Pharma Regulatory Affairs  Consultants Thane-mumbai profile-updat...
Raaj Global Pharma Regulatory Affairs Consultants Thane-mumbai profile-updat...Rajashri Survase Ojha
 
Latest Developments in and the Future of the Regulatory Landscape for Approv...
Latest Developments in and the Future of the  Regulatory Landscape for Approv...Latest Developments in and the Future of the  Regulatory Landscape for Approv...
Latest Developments in and the Future of the Regulatory Landscape for Approv...Michael Swit
 
Regulatory affair - Introduction
Regulatory affair - IntroductionRegulatory affair - Introduction
Regulatory affair - IntroductionDr. Jigar Vyas
 
Regulatory affairs
Regulatory affairsRegulatory affairs
Regulatory affairssekhara
 
Common Technical Document
Common Technical DocumentCommon Technical Document
Common Technical DocumentDr Sukanta sen
 

What's hot (20)

COMBINATION PRODUCTS – Perspectives on FDA Regulation
COMBINATION PRODUCTS – Perspectives on FDA RegulationCOMBINATION PRODUCTS – Perspectives on FDA Regulation
COMBINATION PRODUCTS – Perspectives on FDA Regulation
 
Marketing Authorization In The Eu
Marketing Authorization In The EuMarketing Authorization In The Eu
Marketing Authorization In The Eu
 
Presentation: Implementing TGO 101
Presentation: Implementing TGO 101Presentation: Implementing TGO 101
Presentation: Implementing TGO 101
 
"Scientific Exchange -- New Interpretations??"
"Scientific Exchange -- New Interpretations??""Scientific Exchange -- New Interpretations??"
"Scientific Exchange -- New Interpretations??"
 
Federal Regulatory Issues Us Food And Drug Administration Medical Device Amen...
Federal Regulatory Issues Us Food And Drug Administration Medical Device Amen...Federal Regulatory Issues Us Food And Drug Administration Medical Device Amen...
Federal Regulatory Issues Us Food And Drug Administration Medical Device Amen...
 
Pharmaceutical Industry Terminology
Pharmaceutical Industry TerminologyPharmaceutical Industry Terminology
Pharmaceutical Industry Terminology
 
Overview of FDA Drug Manufacturing Requirements
Overview of FDA Drug Manufacturing RequirementsOverview of FDA Drug Manufacturing Requirements
Overview of FDA Drug Manufacturing Requirements
 
Exam no. 76 ashma
Exam no. 76 ashmaExam no. 76 ashma
Exam no. 76 ashma
 
Eu and usa key differences 1
Eu and usa key differences 1Eu and usa key differences 1
Eu and usa key differences 1
 
Basic concepts about regulatory affairs
Basic concepts about regulatory affairsBasic concepts about regulatory affairs
Basic concepts about regulatory affairs
 
Recall of ph product
Recall of ph productRecall of ph product
Recall of ph product
 
Drug Regulatory Affairs
Drug Regulatory AffairsDrug Regulatory Affairs
Drug Regulatory Affairs
 
Clinical research : Drug regulatory affairs and Pharmacovigilance.
Clinical research : Drug regulatory affairs and Pharmacovigilance.Clinical research : Drug regulatory affairs and Pharmacovigilance.
Clinical research : Drug regulatory affairs and Pharmacovigilance.
 
Introduction to Regulatory Affairs - Pauwels Consulting Academy
Introduction to Regulatory Affairs  - Pauwels Consulting AcademyIntroduction to Regulatory Affairs  - Pauwels Consulting Academy
Introduction to Regulatory Affairs - Pauwels Consulting Academy
 
Presentation Therapeutic Goods (Standard for Tablets, Capsules and Pills) (TG...
Presentation Therapeutic Goods (Standard for Tablets, Capsules and Pills) (TG...Presentation Therapeutic Goods (Standard for Tablets, Capsules and Pills) (TG...
Presentation Therapeutic Goods (Standard for Tablets, Capsules and Pills) (TG...
 
Raaj Global Pharma Regulatory Affairs Consultants Thane-mumbai profile-updat...
Raaj Global Pharma Regulatory Affairs  Consultants Thane-mumbai profile-updat...Raaj Global Pharma Regulatory Affairs  Consultants Thane-mumbai profile-updat...
Raaj Global Pharma Regulatory Affairs Consultants Thane-mumbai profile-updat...
 
Latest Developments in and the Future of the Regulatory Landscape for Approv...
Latest Developments in and the Future of the  Regulatory Landscape for Approv...Latest Developments in and the Future of the  Regulatory Landscape for Approv...
Latest Developments in and the Future of the Regulatory Landscape for Approv...
 
Regulatory affair - Introduction
Regulatory affair - IntroductionRegulatory affair - Introduction
Regulatory affair - Introduction
 
Regulatory affairs
Regulatory affairsRegulatory affairs
Regulatory affairs
 
Common Technical Document
Common Technical DocumentCommon Technical Document
Common Technical Document
 

Similar to WBR Company Intro Master Jan 16

Quality regulation for biological products current and future
Quality regulation for biological products current and futureQuality regulation for biological products current and future
Quality regulation for biological products current and futureNational Institute of Biologics
 
2011 Webinar on Medical Devices: EU Directives, Guidance Documents, CE Markin...
2011 Webinar on Medical Devices: EU Directives, Guidance Documents, CE Markin...2011 Webinar on Medical Devices: EU Directives, Guidance Documents, CE Markin...
2011 Webinar on Medical Devices: EU Directives, Guidance Documents, CE Markin...supportc2go
 
Drug Safety Regulations In The Us And Eu
Drug Safety Regulations In The Us And EuDrug Safety Regulations In The Us And Eu
Drug Safety Regulations In The Us And EuAngelinabarfield
 
cmc [ chemistry manufacturing control ]
cmc [ chemistry manufacturing control ]cmc [ chemistry manufacturing control ]
cmc [ chemistry manufacturing control ]Akshay Patil
 
The Importance of Developing a Global Regulatory Strategy towards the Goal of...
The Importance of Developing a Global Regulatory Strategy towards the Goal of...The Importance of Developing a Global Regulatory Strategy towards the Goal of...
The Importance of Developing a Global Regulatory Strategy towards the Goal of...Life Sciences Network marcus evans
 
Usfda, who guidline and iso 9000 series
Usfda, who guidline and iso 9000 seriesUsfda, who guidline and iso 9000 series
Usfda, who guidline and iso 9000 seriesChanrashekhar jain
 
Ed Ball - Liverpool City Region SME workshop: Regulatory process and approval
Ed Ball - Liverpool City Region SME workshop: Regulatory process and approval	Ed Ball - Liverpool City Region SME workshop: Regulatory process and approval
Ed Ball - Liverpool City Region SME workshop: Regulatory process and approval Innovation Agency
 
Bayer HealthCare Overview
Bayer HealthCare OverviewBayer HealthCare Overview
Bayer HealthCare Overviewbhcbelgium
 
Presentation China And Usa July 2011
Presentation   China And Usa July 2011Presentation   China And Usa July 2011
Presentation China And Usa July 2011roeandjoe
 
Fundamental concept of regulatory affairs in pharmaceutical & biotechnology
Fundamental concept of regulatory affairs in pharmaceutical & biotechnologyFundamental concept of regulatory affairs in pharmaceutical & biotechnology
Fundamental concept of regulatory affairs in pharmaceutical & biotechnologyHitendra Singh
 
Learn more about Pharmalink
Learn more about PharmalinkLearn more about Pharmalink
Learn more about Pharmalinksloughrey
 
CE Marking & US FDA for Medical devices
CE Marking & US FDA for Medical devicesCE Marking & US FDA for Medical devices
CE Marking & US FDA for Medical devicesI 3 Consulting
 
Comparative Study of Dossier Compilation & Submission Process of Drug Product...
Comparative Study of Dossier Compilation & Submission Process of Drug Product...Comparative Study of Dossier Compilation & Submission Process of Drug Product...
Comparative Study of Dossier Compilation & Submission Process of Drug Product...DeveshDRA
 
Company Presentation Final June 2008
Company Presentation   Final June 2008Company Presentation   Final June 2008
Company Presentation Final June 2008lspeid
 
PECB Webinar: Proposed changes for medical device quality management systems ...
PECB Webinar: Proposed changes for medical device quality management systems ...PECB Webinar: Proposed changes for medical device quality management systems ...
PECB Webinar: Proposed changes for medical device quality management systems ...PECB
 
presentation-ema-experience-mdr-implementation_en.pdf
presentation-ema-experience-mdr-implementation_en.pdfpresentation-ema-experience-mdr-implementation_en.pdf
presentation-ema-experience-mdr-implementation_en.pdfBalaji Kuzhandhaivelu
 
TGA changes for Medical Devices in Australia
TGA changes for Medical Devices in AustraliaTGA changes for Medical Devices in Australia
TGA changes for Medical Devices in AustraliaJoe Hage
 

Similar to WBR Company Intro Master Jan 16 (20)

Quality regulation for biological products current and future
Quality regulation for biological products current and futureQuality regulation for biological products current and future
Quality regulation for biological products current and future
 
Eu
EuEu
Eu
 
2011 Webinar on Medical Devices: EU Directives, Guidance Documents, CE Markin...
2011 Webinar on Medical Devices: EU Directives, Guidance Documents, CE Markin...2011 Webinar on Medical Devices: EU Directives, Guidance Documents, CE Markin...
2011 Webinar on Medical Devices: EU Directives, Guidance Documents, CE Markin...
 
Drug Safety Regulations In The Us And Eu
Drug Safety Regulations In The Us And EuDrug Safety Regulations In The Us And Eu
Drug Safety Regulations In The Us And Eu
 
cmc [ chemistry manufacturing control ]
cmc [ chemistry manufacturing control ]cmc [ chemistry manufacturing control ]
cmc [ chemistry manufacturing control ]
 
The Importance of Developing a Global Regulatory Strategy towards the Goal of...
The Importance of Developing a Global Regulatory Strategy towards the Goal of...The Importance of Developing a Global Regulatory Strategy towards the Goal of...
The Importance of Developing a Global Regulatory Strategy towards the Goal of...
 
Diteba Research Laboratories Corporate Capabilities
Diteba Research Laboratories Corporate CapabilitiesDiteba Research Laboratories Corporate Capabilities
Diteba Research Laboratories Corporate Capabilities
 
Usfda, who guidline and iso 9000 series
Usfda, who guidline and iso 9000 seriesUsfda, who guidline and iso 9000 series
Usfda, who guidline and iso 9000 series
 
Ed Ball - Liverpool City Region SME workshop: Regulatory process and approval
Ed Ball - Liverpool City Region SME workshop: Regulatory process and approval	Ed Ball - Liverpool City Region SME workshop: Regulatory process and approval
Ed Ball - Liverpool City Region SME workshop: Regulatory process and approval
 
Bayer HealthCare Overview
Bayer HealthCare OverviewBayer HealthCare Overview
Bayer HealthCare Overview
 
Presentation China And Usa July 2011
Presentation   China And Usa July 2011Presentation   China And Usa July 2011
Presentation China And Usa July 2011
 
Fundamental concept of regulatory affairs in pharmaceutical & biotechnology
Fundamental concept of regulatory affairs in pharmaceutical & biotechnologyFundamental concept of regulatory affairs in pharmaceutical & biotechnology
Fundamental concept of regulatory affairs in pharmaceutical & biotechnology
 
Learn more about Pharmalink
Learn more about PharmalinkLearn more about Pharmalink
Learn more about Pharmalink
 
CE Marking & US FDA for Medical devices
CE Marking & US FDA for Medical devicesCE Marking & US FDA for Medical devices
CE Marking & US FDA for Medical devices
 
Comparative Study of Dossier Compilation & Submission Process of Drug Product...
Comparative Study of Dossier Compilation & Submission Process of Drug Product...Comparative Study of Dossier Compilation & Submission Process of Drug Product...
Comparative Study of Dossier Compilation & Submission Process of Drug Product...
 
Company Presentation Final June 2008
Company Presentation   Final June 2008Company Presentation   Final June 2008
Company Presentation Final June 2008
 
PECB Webinar: Proposed changes for medical device quality management systems ...
PECB Webinar: Proposed changes for medical device quality management systems ...PECB Webinar: Proposed changes for medical device quality management systems ...
PECB Webinar: Proposed changes for medical device quality management systems ...
 
Medical Device
Medical DeviceMedical Device
Medical Device
 
presentation-ema-experience-mdr-implementation_en.pdf
presentation-ema-experience-mdr-implementation_en.pdfpresentation-ema-experience-mdr-implementation_en.pdf
presentation-ema-experience-mdr-implementation_en.pdf
 
TGA changes for Medical Devices in Australia
TGA changes for Medical Devices in AustraliaTGA changes for Medical Devices in Australia
TGA changes for Medical Devices in Australia
 

WBR Company Intro Master Jan 16

  • 1. Woodley BioReg Limited Company and Services Overview WBR JAN 2016
  • 2. Woodley BioReg Limited WoodleyBioReg  Company Background  Services  Regulatory Affairs Support  Quality Support  Import Services  Training Services  Areas of Expertise  Examples of Products Registered and Maintained by WBR  Examples of Current Global Projects
  • 3. Company Background WoodleyBioReg  Established in 2001  Headquarters in the UK  Permanent Employees reinforced by a network of Specialist Associates  Operate Globally  Europe, USA, India, China, South Korea Australia………..
  • 4. Services WoodleyBioReg  Provide Regulatory, Quality, Import Services and Training  Work with you, the manufacturers and suppliers of:  Biopharmaceuticals / biologics / biosimilars  Pharmaceuticals  Generics  Healthcare / Over-the-Counter Medicines  Active Pharmaceutical Ingredients (APIs)  Medical Devices Training Import Services QualityRegulatory
  • 5. WoodleyBioReg Overview of EU cGMP Registration Process Registration cGMP Gap Analysis Audit Technical Plant/ Documents Review/Finalise Submission Draft Submission Submit (Nees / eCTD) to BoH / EMA EU Audit Approval Market Product Remediation Report Remediation Deficiencies Audit and Approval Maintain cGMP Compliance Existing Reg. Affairs Docs
  • 6. Regulatory Affairs Support – Key Services WoodleyBioReg  Flexible Resourcing  Day-to day support for function activities  Qualified resources with 2 to 25+ years of experience  Ex-Industry, ex-Agency (MHRA, BfArM, EMA, Health Canada, FDA, etc.)  Registration Drift  MA compliance and conformance assessment  Agency “approved” dossier review and remediation procedure - published  Applied to over 8,000 MAs  Permanent fix that link the MAs into change control procedures  Licence Makeover  Allows easy maintenance of well-established products  Simplifies variations  Can be combined with other initiatives, e.g. Registration Drift  Import Service  Allows non-EU clients to make a soft landing for EU commercialisation
  • 7. Regulatory Affairs Support – Flexible Resourcing WoodleyBioReg  Submission Strategy Development  DCP / MRP / CP / duplicate licences / COO etc.  Write and submit Marketing Authorisations / Product Licences  m1 through to m5  Publishing - NeeS (EU) or eCTD (US)  Respond to Requests for Information (RFIs)  Attend Agency Meetings with Boards of Health (and Scientific Advice)  Licence Maintenance / Life-Cycle Management  Change of ownership  Variations and Renewals  Compliance and Conformance specialists for top tier pharmaceutical companies  Provide EU Regulatory Affairs office for overseas (non-EU) clients
  • 8. Regulatory Affairs Support – Registration Drift WoodleyBioReg Gap Analysis Load RemediationCollation Risk-based Schedule Prioritise products, collect MAs, collate details in a single central location, and prepare to perform a GAP ANALYSIS Prepare and file variations to align the MAs and maintain under Change Control Compare MA sections to Plant / Manufacturing documents, prioritise the differences.
  • 9. Regulatory Affairs Support – Licence Makeover WoodleyBioReg 3.2.P.1 DS DP PDF NtA Scans PDF NtA Scans PDF NtA Scans Paper PDF NtA Scans Variations 3.2.S.1 eRepository Current MAs, Variations, etc Extracted and organised into CTD (DS / DP) folders Compliance and Conformance reviewed CTD / SRC dossier sections MA Visibility / Maintenance (under CC) Extraction Reformat & Review Extraction 1. Take source documents, Scan/OCR 2. Split into DS / DP sections 3. No rewriting undertaken Reformat & Review 1. Convert into CTD format (templated) 2. Re-write parts as necessary 3. Review content against CTD requirements 4. Identify Gaps / Remediate through variation Load - WBR / Client for Scan / OCR (where available) - WBR for load - Client for ongoing maintenance - WBR for review, reformatting and Gap Analysis
  • 10. Import Services WoodleyBioReg  Provide EU address  Laboratory Testing Services:  Full release  Batch release  Identity  Product quality specification (PQS)  Stability - storage (temperature and humidity controls) and indicating  QP sign-off for batch release  PV contact for Adverse Event reporting (see later)  Secure, controlled storage of GMP pharmaceutical products  Shipping and distribution within the EU  All of the above services are EU legal requirements governed by  Manufacturer’s Importer’s Authorisation (MIA)  Wholesale Dealers Licence (WDL)
  • 11. Quality Support WoodleyBioReg  cGMP standards and certification (EU and US)  Contract QP services (biologics and pharmaceuticals including steriles)  Full validation and documentation assessment and remediation / re-writes  Issue WBR EU registered QP certificate  Quality Management / Quality Assurance System  Development, refinement/ amendment and deployment of QMS  Pharmacovigilence  Including contract QPPV services  Auditing  Self-Audits  Due diligence  Third party manufacturers  Remediation plans and assistance  Training  GMP and Regulatory Affairs
  • 12. Pharmacovigilence Support WoodleyBioReg  EU QPPV Provision  Pharmacovigilance System Master File (PSMF)  generation and maintenance  Receipt and processing of Serious Adverse Events (SAE) onto ARISg  Medical Review of ADR reports and submission of expedited reports  Literature searches (required for PV reporting)  Periodic Safety Updates (PSURs)  preparation and distribution of Risk Management Plans (RMPs)  Signal detection  EVMPD (PV database) maintenance  Audits, training and any other incidentals
  • 13. Training Services WoodleyBioReg  cGMP and Quality Systems Requirements  Regulatory Affairs Submissions  New Variation Guidelines  Introduction to European Regulatory Affairs  How to Register Biosimilars to “Global Standards”  Pre-approval Inspection Requirements for the US FDA  How to Audit to cGMP - what to look for in self-audits  Identification and Validation of Critical Manufacturing Process Steps
  • 14. Areas of Expertise WoodleyBioReg  Biologics / Vaccines  Biosimilars  Pharmaceuticals / Generics  Healthcare / OTC  Devices (including Drug Device combinations)  Steriles including pre-filled syringes  Advanced Therapeutic Medicinal Products (ATMPs)  Orphan Products  Metered Dose Inhalers  Solid dose, gels, and capsules  Topicals (creams and ointments)
  • 15. Products WBR have Registered and Maintained WoodleyBioReg Examples of products WBR registered and maintained in the EU and US:  Alpha-reductus Inhibitors  Analgesic  Anti-anxiety  Antibiotic  Anticholinesterase  Anticonvulsants  Antidepressants  Anti-epileptic  Antihypertensive  Antihistamines  Anti-platlets  Antipsychotic  Bi-phosphonates  Cholinesterase Inhibitors  Diuretics  Immunosuppressants  Laxatives  Leukotriene Receptor Antagonists (Asthma)  Meglitinides (Diabetes)  Oncology  Proton Pump Inhibitors  Sedatives  Statins  Steroids  Vaccines  Anthrax  Diphtheria  Hepatitis B  Influenza  Meninge  Pertussis  Tetanus  Typhoid  Yellow Fever  Vitamin D products
  • 16. Current Global Projects WoodleyBioReg  EU and US Registrations  Statins / Anti-depressants / Anti-hypertensives / Analgesics / Combination products / Vaccines etc.  For Chinese and Indian generics manufacturers  EU Regulatory and Quality department  Long-term provision of EU “virtual” regulatory department for an Indian generics manufacturer  Submission of all filings to EU Boards of Health  Quality Management System (QMS) implementation  Scoping, writing, implementation and ongoing management of a QMS for the UK division of a Chinese international generics manufacturer  Global Conformance Review  Review of >2,000 over-the-counter healthcare products for a multi-national pharmaceutical company  Quality Audit of a Manufacturer  Due diligence audit of a Korean biologics manufacturing company prior to US acquisition
  • 17. Regulatory and Quality Experts www.woodleybioreg.com E: enquiry@woodleybioreg.com T: +44 (0)1484 434343 Midland Mill, 9-11 Hillhouse Lane, Huddersfield, West Yorkshire, HD1 6EF, UK